Jacks Lee - 15 Jun 2023 Form 4 Insider Report for G1 Therapeutics, Inc.

Role: Director
Signature: /s /Sandi James, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 15 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 16 Jun 2023, 16:06:53 UTC
Previous filing: 29 Jun 2022
Next filing: 29 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GTHX	Common Stock	Award	$0	+10,000		$0.000000	10,000	15 Jun 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GTHX	Stock Options (Right to Buy)	Award	$0	+30,000		$0.000000	30,000	15 Jun 2023	Common Stock	30,000	$2.83	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 15, 2023, subject to the Reporting Person's continued service as a director.
F2	Each RSU represents a contingent right to receive one share of Issuer common stock.
F3	The shares underlying this option will vest in their entirety twelve months after June 15, 2023, subject to the Reporting Person's continued service as a director.